Results 21 to 30 of about 120,136 (313)

Breast cancer as photodynamic therapy target: Enhanced therapeutic efficiency by overview of tumor complexity [PDF]

open access: yes, 2014
Photodynamic therapy is a minimally invasive and clinically approved procedure for eliminating selected malignant cells with specific light activation of a photosensitizer agent.
Lamberti, María Julia   +2 more
core   +1 more source

Low dose novel PARP-PI3K inhibition via nanoformulation improves colorectal cancer immunoradiotherapy

open access: yesMaterials Today Bio, 2020
Multimodal therapy is often used in oncology to overcome dosing limitations and chemoresistance. Recently, combination immunoradiotherapy has shown great promise in a select subset of patients with colorectal cancer (CRC).
M.R. Landry   +6 more
doaj   +1 more source

Dinitroazetidines Are a Novel Class of Anticancer Agents and Hypoxia-Activated Radiation Sensitizers Developed from Highly Energetic Materials [PDF]

open access: yesCancer Research, 2012
Abstract In an effort to develop cancer therapies that maximize cytotoxicity, while minimizing unwanted side effects, we studied a series of novel compounds based on the highly energetic heterocyclic scaffold, dinitroazetidine. In this study, we report the preclinical validation of 1-bromoacetyl-3,3-dinitroazetidine (ABDNAZ), a ...
Shoucheng, Ning   +5 more
openaire   +3 more sources

First examples of pyran based colorants as sensitizing agents of p-Type Dye-Sensitized solar cells [PDF]

open access: yes, 2017
Three different pyran based dyes were synthesized and tested for the first time as photosensitizers of NiO based p-type dye-sensitized solar cells (p-DSSC).
Bonomo, Matteo   +4 more
core   +1 more source

Cross-sensitivity to DNA-damaging agents in radiation-sensitive mutants of murine leukemia cells. [PDF]

open access: yesJournal of Radiation Research, 1986
Two independently isolated radiation-sensitive mutants, M10 and LX830, of mouse L5178Y cells were compared for their sensitivity to various DNA-damaging agents. These two mutants share hypersensitivity to gamma rays, bleomycin, arabinofuranosyl cytosine (Ara-C) and aphidicolin.
K, Sato   +4 more
openaire   +2 more sources

Mechanisms for Tuning Engineered Nanomaterials to Enhance Radiation Therapy of Cancer

open access: yesAdvancement of science, 2020
Engineered nanomaterials that produce reactive oxygen species on exposure to X‐ and gamma‐rays used in radiation therapy offer promise of novel cancer treatment strategies.
Sandhya Clement   +7 more
semanticscholar   +1 more source

Does particle radiation have superior radiobiological advantages for prostate cancer cells? A systematic review of in vitro studies

open access: yesEuropean Journal of Medical Research, 2022
Background Charged particle beams from protons to carbon ions provide many significant physical benefits in radiation therapy. However, preclinical studies of charged particle therapy for prostate cancer are extremely limited.
Tian-Qi Du   +12 more
doaj   +1 more source

Targeting ATM pathway for therapeutic intervention in cancer [PDF]

open access: yes, 2012
The Ataxia Telangiectasia Mutated gene encodes the ATM protein, a key element in the DNA damage response (DDR) signalling pathway responsible for maintaining genomic integrity within the cell.
Chakarov, Stoyan   +4 more
core   +3 more sources

Efficiency Comparison between Radiotherapy Alone And In The Presence of Radio- or Photo- Sensitizers on Viability of DFW and HT29 Cell Lines: From Simulations to Experimental Results [PDF]

open access: yesIranian Journal of Medical Physics
Introduction: Radiotherapy (RT) is a conventional cancer treatment which address needs of most cancerous patients. However, toxicity of high X-ray energies increases side effects to the normal tissues.
Farideh Hosseini   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy